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Introduction
A healthy human vagina is primarily colonized by 
the genus Lactobacillus (Shiraishi et al. 2011) and it 
builds a barrier separating the pathogens from the epi-
thelium, thereby, protecting the vagina. The pH ~ 4.5 
also maintains the balance of the vaginal ecosystem as 
well as antimicrobial substances e.g. hydrogen peroxide 
against pathogens (Ayeni and Adeniyi 2013; Ghartey 
2014). Occasional and recurrent vaginal yeast and bac-
terial imbalances are common among premenopausal 
women, which can be due to hormonal changes during 
menstrual cycle, antibiotic treatment, pregnancy, sexual 
intercourse, excessive intimate hygiene and use of tam-
pons, which may predispose a woman to infections.
The hormonal changes occur during the repro-
ductive stages with the resulting fluctuating levels of 
hormones that regulate the menstrual cycle. This is an 
important influence on the vaginal microbiota during 
human reproductive years (Farage et al. 2010). Women 
of different racial groups may exhibit different compo-
sition of microbial communities and, correspondingly, 
different susceptibility to vaginal infections. Women 
are more prone to urinary tract infections (UTI) than 
men due to the position of the urethra. The reduction 
in protective vaginal flora may increase the risk of these 
infections (Gupta et al. 2017).
Lactic acid bacteria (LAB) have been shown to 
inhibit the in vitro growth of pathogenic microorgan-
isms, e.g. Klebsiella spp. Neisseria gonorrhoeae, Pseudo­
monas aeruginosa, Candida albicans, Staphylococcus 
aureus, Escherichia coli, etc. (Ayeni and Adeniyi 2012; 
Adeoshun and Ayeni 2016). This can be achieved 
mainly through the action of lactic acid (Graver and 
Wade 2011). During menstruation, the diminished 
population of lactobacilli and the presence of men-
strual fluid make the vaginal less acidic, therefore, more 
prone to colonization by pathogenic microorganisms. 
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A b s t r a c t
The composition of vagina lactic acid bacteria (LAB) differs within the different ethnic group. This study is aimed at determining the preva-
lence of LAB with their antimicrobial properties in Nigerian women’s vagina during different stages of the menstrual cycle. Microorganisms 
were isolated from vaginal swabs of ten Nigerian women during different stages of the menstrual cycle and identified by partial sequencing 
of the 16S rRNA gene. The antimicrobial properties of the LAB were tested against the multidrug-resistant uropathogens. The prevalence of 
LAB was higher during ovulation period while during menstruation period, it declined. Twenty-five LAB isolates were identified as three 
species, namely: Lactobacillus plantarum (15), Lactobacillus fermentum (9), Lactobacillus brevis (1) and one acetic acid bacteria – Acetobacter 
pasteurianus. The LAB had antimicrobial activities against the three uropathogens with zones of inhibition from 8 to 22 mm. The presence 
of LAB inhibits the growth of Staphylococcus sp. GF01 also in the co-culture. High LAB counts were found during ovulation period with 
L. plantarum as a dominant species while during menstruation, there was a decrease in the LAB counts. The isolated LAB has antimicrobial 
properties against the urogenital pathogens tested thus exhibiting their potential protective role against uropathogens.
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Changes between different bacterial species in the 
vagina are associated with menses (Gajer et al. 2012).
The antimicrobial activity of the vaginal fluids corre-
lates with an increased lactic acid content, low pH and 
competitive exclusion. The increased susceptibility to 
disease may be also related to vaginal microbiota fluc-
tuations (Gajer et al. 2012). Ayeni and Adeniyi (2013) 
and Agboola et al. (2014) had reported the presence of 
organisms in healthy and menstruating women with 
their antimicrobial properties in Nigeria. However, 
there is no information to establish changes in vaginal 
microbiota at different stages of the menstrual cycle and 
the antimicrobial effects of the isolated LAB. Therefore, 
this study aimed at determining the prevalence of LAB 
at different stages of the menstrual cycle in Nigerian 
women with their potential antimicrobial properties.
Experimental
Materials and Methods
Pathogens. Ten clinical strains of uropathogens: 
Kleb siella spp., Staphylococcus spp. and Pseudomonas 
spp. (isolated from urine) were collected from the 
culture collection of the Medical Microbiological 
Laboratory of the University College of Medicine 
(UCH), Ibadan.
Sample collections, isolation, and lactic acid bacte-
ria viability counts. Ethical approval (UI/EC/13/0258) 
was obtained from the Institutional Ethical Commit-
tee (IEC), Institute for Advanced Medical Research and 
Training (IAMRAT), College of Medicine, University 
of Ibadan, Ibadan, Nigeria. Ten Nigerian women vol-
unteers aged between 20–40 years were recruited into 
this study. They were premenopausal, self-declared 
healthy, not on antibiotics or hormonal therapy for at 
least four months, not on contraceptives, having regular 
menstrual cycle, i.e. a complete menstrual cycle between 
25–30 days every month, and exhibiting the three dif-
ferent stages within the cycle. For each volunteer, Day 1 
of menstrual flow is noted as day one of the menstrual 
cycle. For a five-days flow, samples were taken on day 3 
and for a 4-days flow, samples were taken on day 2. Safe 
period is between 6th–12th day of the menstrual cycle 
while the ovulation period is between 13th–15th day of 
the menstrual cycle. The safe period samples were taken 
on day 6 after menstrual flow stopped. The ovulation 
period samples were obtained midway of the menstrual 
cycle. The signed informed consent was obtained from 
each volunteer. The samples were collected from the vol-
unteers during different stages of their menstrual cycle 
between August and September 2014. The volunteers 
used sterile swab sticks to swab the vagina according to 
the standard protocols. The samples were collected dur-
ing the three different stages of the menstrual cycle and 
immediately inoculated in 10 ml MRS broth, (Oxoid, 
UK) adjusted to pH 5, shaken vigorously for 10 s and 
incubated under the microaerophilic condition using 
CampyGenTM at 37°C for 24 h. Serial dilutions were 
done using sterile normal saline and the suspension of 
the suitable dilution factor was plated out on MRS agar 
by pour plate method, then incubated under micro-
aerophilic condition at 37°C for 48 h. The initial colony 
counts were noted and colonies were picked according 
to the differences in their colony morpho logy on MRS 
agar plates and isolated by streaking onto another MRS 
agar to obtain a distinct colony. Gram staining and cat-
alase test were carried out and only the colonies that 
were Gram-positive and catalase-negative were picked 
and stored in MRS broth containing 20% w/v glycerol 
at –20°C for further characterization and identification.
Identification of Lactic Acid Bacteria. The DNA of 
the LAB isolated were extracted by QuickExtractTM DNA 
extraction solution (Epicentre, Wisconsin) according to 
the manufacturer’s instructions. The PCR mixture con-
sisted of a total volume of 20 µl (1 µl of DNA extract, 
10 pmol of each primer, and 25 µl of 2-fold concen-
trated RedTaq Ready Mix (SigmaAldrich, Germany)). 
The primers used for amplification were (5’-TGTAA
AACGGCCAGTAGAGTTTGATC(AC)TGGCTCAG) 
and (5’-CAGGAAACAGCTATGACCG(AT)ATTAC 
CGCGGC(GT)GCTG), containing an M13 primer 
sequence (Montanaro et al. 2016). PCR conditions 
were 95°C for 5 min; 35 cycles each of 95°C for 15 s, 
58°C for 30 s, and 72°C for 45 s; and a final step at 72°C 
for 10 min. Ten microliters of the amplified products 
were analyzed on 1.5% agarose gels and subsequently 
sequenced using the BigDye Terminator v3.1 sequenc-
ing kit (Applied Biosystems, California). The sequence 
was blasted against the NCBI database for species iden-
tification. The nucleotide sequences for the 16S rRNA 
genes have been deposited in the GenBank database 
under accession numbers KX261342 to KX261366.
Antibiotic susceptibility of uropathogens. Ten uro - 
pathogenic strains were collected and screened against 
seven antibiotics by disk diffusion methods. A bacterial 
lawn was accomplished by spreading inoculum from 
108 dilution factor of the pathogen culture which is 
approximately equivalent to 0.5 McFarland standards 
by a sterile swab stick. The antibiotic disks containing 
ceftazidime (30 µg), cefotaxime (30 µg), cefuroxime 
(30 µg), Augmentin (amoxicillin clavulanate) (10 µg), 
ciprofloxacin (30 µg), ofloxacin (30 µg), and gentamycin 
(30 µg) were placed on the surface of the solidified agar 
with the aid of sterile forceps and incubated aerobically 
at 37°C for 24 h. The susceptibility of the test organ-
isms to the antibiotics used was documented by meas-
uring the diameter of the clear zones of inhibition in 
millimeter (mm) around the antibiotics disks, and the 
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results were interpreted according to the guidelines of 
European Committee on Antimicrobial Susceptibility 
Testing (2015). The resistant strains were selected for 
LAB antimicrobial study.
Determination of LAB antimicrobial activities 
against bacterial uropathogens. To study the anti- 
microbial potential of the LAB against clinical iso-
lates of uropathogens, three different methods were 
employed, which are: using the cell free supernatant 
via agar well diffusion method, using the viable LAB 
cells via agar overlay method, and co-culture of the 
LAB and uropathogens.
Determination of the antimicrobial activity of the 
cell-free supernatant. The LAB isolates were grown in 
MRS broth overnight under the microaerophilic condi-
tion at 37°C, centrifuged at 10 000 rpm for 10 min and 
the supernatant decanted. The antimicrobial activities 
of the cell-free supernatant were determined twice, 
i.e. before and after neutralization to pH of 6.5 with 
1 M NaOH, using the agar well diffusion assay against 
Staphylococcus sp. GF01, Pseudomonas aeruginosa GF01, 
and Klebsiella sp. GF01.
Determination of the antimicrobial activity of 
viable lactic acid bacterial cells. The modified agar 
overlaid method as described by Ayeni et al. (2011) was 
used in this study. In summary, the LAB cells in broth 
were inoculated in two 2-cm-long lines on an MRS 
agar surface and then incubated at 37°C for 24–48 h 
in microaerophilic conditions. The plates were over-
laid with 0.2 ml of an overnight broth culture of the 
test pathogen vehiculated in 10 ml soft nutrient agar 
and incubated at 37°C under aerobic condition. The 
plates were then examined for a clear zone of inhibition 
around the line of the LAB and the clear zones were 
measured in millimeters.
Coculture of lactic acid bacteria and uropatho-
gens. The interference of the LAB strains with the 
growth of uropathogenic strains was evaluated by 
coincubating Staphylococcus sp. GF01 with four rep-
resentative strains of LAB (Lactobacillus brevis GF021, 
obtained from the menstruation period, Lactobacilus 
fermentum GF002, Lactobacillus plantarum GF011, 
obtained from the safe period and Lactobacillus fer­
mentum GF019, obtained from the ovulation period). 
This was done in two series of experiments.
In the first experiment, an overnight culture of 
Staphylococcus sp. GF01 was inoculated into 5 ml dou-
ble strength nutrient broth and then added to 5 ml of 
overnight culture of the LAB and the mixture was incu-
bated for 24 h. The monoculture of the mixture, the 
LAB and Staphylococcus sp. GF01 (control) was evalu-
ated at time zero (t0) and after incubation. For the sec-
ond experiment, 5 ml of Staphylococcus sp. GF01 was 
incubated for 8 h, after which it was centrifuged and the 
supernatant discarded, 5 ml of double strength nutri-
ent broth was added to resuspend the pellets, vortexed 
and added to a 5 ml of overnight culture of the LAB. 
Staphylococcus sp. GF01 monoculture and the mixture 
was plated out at 8 h and 24 h to evaluate the growth 
of Staphylococcus sp. GF01.
Results
The three organisms used exhibited high resistance 
(i.e. 0 mm zones of inhibition) towards most of the 
antibiotics used. The Pseudomonas and Staphylococcus 
strains tested were resistant to ceftazidime, cefotaxime, 
cefuroxime, Augmentin (amoxicillin clavulanate) but 
sensitive to ciprofloxacin, ofloxacin, and gentamycin, 
while the Klebsiella sp. GF01 strain was completely 
resistant to all the antibiotics.
Ten volunteers were assessed for a level of LAB in 
their vagina at different stages of the menstrual cycle. 
It was observed that in seven (70%) out of the ten vol-
unteers, there was a significant shift of the LAB level 
from low to high (8 × 105 to 7.6 × 109) CFU/ml over 
the course of the menstrual cycle. In the remaining 
three (30%) volunteers, the presence of LAB was not 
observed throughout the menstrual cycle (Table I).
A total of twenty-seven (27) bacterial species were 
identified from the three different stages of menstrual 
cycle as five species (L. plantarum (15), L. fermen­
tum (9), Lactobacillus brevis (1), Bacillus safensis (1) 
and Acetobacter pasteurianus (1)) and their percent-
age occurrence at different stages of the menstrual 
cycle was shown in Table I. Twenty-five (25) isolates 
(92.59%) belonging to the genus Lactobacillus occurred 
in the three stages, while one (1) isolate (3.70%) each 
belonged to Bacillus and Acetobacter, both noted dur-
ing safe (follicular) period, only. The organism with the 
highest frequency of occurrence (60%) among the Lac­
tobacillus species was L. plantarum and it constituted 
55.55% among all the isolates studied, and its highest 
occurrence was during the ovulation period. L. brevis 
has the lowest frequency of occurrence of 4% among 
the Lactobacillus spp. and 3.7% among the total isolates, 
and it occurred during the menstruation period.
The cell-free supernatants and viable cells showed 
a clear inhibitory antimicrobial activity against Pseu­
domonas aeruginosa GF01, Klebsiella sp. GF01 and 
Staphylococcus sp. GF01. Out of 27 LAB isolates used 
against P. aeruginosa GF01, 20 (74.07%) of the iso-
lates had zones of inhibition ranging from 8 to 22 mm 
against Klebsiella sp. GF01, 24 (88.89%) had zones of 
inhibition ranging from 10 to 20 mm, while 20 (74.07%) 
had inhibition zones ranging from 10 to 20 mm against 
Staphylococcus sp. GF01. Staphylococcus sp. GF01 was 
the least susceptible to the LAB isolated while Kleb­
siella sp. GF01 was the most susceptible (Table II). 
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 1 1.02 × 108 4.2 × 107 1.81 × 1010 9.3 × 109 2.22 × 1010 1.51 × 1010
 2 5.6 × 107 1.0 × 106 1.91 × 1010 5.2 × 109 1.90 × 1010 1.14 × 1010
 3 7.8 × 107 1.2 × 106 1.89 × 1010 7.4 × 109 2.53 × 1010 1.51 × 1010
 4 7.0 × 107 2.2 × 106 1.87 × 1010 1.89 × 1010 9.8 × 109 –
 5 9.2 × 107 1.4 × 106 1.52 × 1010 4.2 × 109 1.87 × 1010 1.02 × 1010
 6 6.1 × 107 8 × 105 8.3 × 109 3.0 × 109 1.12 × 1010 7.6 × 109
 7 1.13 × 108 2.5 × 106 2.11 × 1010 5.4 × 109 3.26 × 1010 1.02 × 1010
 8 2.0 × 103 Nil 1.05 × 104 – 1.05 × 104 Nil
 9 3.8 × 103 Nil 8.5 × 103 – 5.8 × 103 Nil
10 4.2 × 103 Nil 1.12 × 104 – 8.5 × 103 Nil
Table I
Evaluation of the LAB counts at different stages of the menstrual cycle.
Note – Nil means no count of bacteria
Week
Menstruation Period Safe Period Ovulation Period
Total CFU/ml LAB CFU/ml Total CFU/ml LAB CFU/ml LAB CFU/mlTotal CFU/ml
L. fermentum GF002 16 12 20 20 15 20
A. pasteurianus GF004 20 13 0 20 18 12
L. plantarum GF005 15 14 0 18 20 0
L. fermentum GF006 15 14 12 18 20 15
L. plantarum GF007 20 10 15 20 15 18
L. fermentum GF008 15 15 15 20 18 18
L. plantarum GF009 10 12 13 19 20 15
L. plantarum GF010 20 12 10 15 20 20
L. plantarum GF011 22 13 17 20 16 20
L. fermentum GF012 19 14 0 20 20 18
L. fermentum GF013 22 12 0 13 18 20
L. plantarum GF015 18 10 0 20 15 20
L. plantarum GF016 19 12 0 20 20 20
L. fermentum GF018 19 20 20 20 20 15
L. fermentum GF019 18 20 16 20 15 20
L. brevis GF021 19 20 15 20 20 20
L. plantarum GF022 8 10 0 0 20 15
L. plantarum GF023 10 0 0 12 15 0
L. fermentum GF024 14 13 15 12 15 15
L. plantarum GF025 10 15 0 10 18 0
L. fermentum GF026 0 18 0 0 18 0
L. plantarum GF029 0 0 0 0 0 0
L. plantarum GF030 0 0 0 10 0 0
B. safensis GF031 0 13 0 10 15 0
L. plantarum GF032 0 10 0 0 10 0
L. plantarum GF033 0 18 18 10 18 18
L. plantarum GF036 0 10 0 0 12 0
Table II
Determination of the antimicrobial activity of the cell-free supernatant and viable cells.
Cell-free supernatant Viable Cell*
P. aeruginosa
GF01
Klebsiella sp.
GF01
Staphylococcus sp.
GF01
P. aeruginosa
GR01
Klebsiella sp.
GR01
Staphylococcus sp.
GF01
* Antimicrobial activity is expressed as diameters of inhibition zones in mm
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After the neutralization of the cell-free supernatant, 
no obvious antimicrobial activity was observed against 
the uropathogens.
The capability of the LAB strains to inhibit the in 
vitro growth of Staphylococcus sp. GF01 was evaluated 
in coculture experiment which was carried out in two 
parts. In the first experiment, L. brevis GF021 was active 
against Staphylococcus sp. GF01 with 6 log10 reduction 
after 24 h, had and 5 log10 reduction of Staphylococcus 
sp. GF01 after incubation with L. fermentum GF002 or 
L. plantarum GF011. L. fermentum GF019 had a  low 
activity against Staphylococcus sp. GF01, which dem-
onstrated only 3 log10 reduction in numbers of CFU. 
It was observed that Staphylococcus sp. GF01 did not 
have an effect on any of the LAB strains (Fig. 1). In the 
second experiment, Lactobacillus brevis GF021 was 
active against Staphylococcus sp. GF01 with a  6 log10 
reduction. L. fermentum GF002 and L. plantarum 
GF011 were not active against Staphylococcus sp. GF01 
while L. fermentum GF019 showed a low activity against 
Staphylococcus sp. GF01 with just 1 log10 reduction. 
L. fermentum GF019 had the least activity and L. brevis 
GF021 had the highest activity (6 log10 reduction) on 
Staphylococcus sp. GF01 (Fig. 2).
Discussion
The resistance to broad-spectrum antibiotics is 
a persistent challenge in the management of infections 
(Ayeni et al. 2011). In this study, Klebsiella sp. GF01, 
P. aeruginosa GF01 and Staphylococcus sp. GF01 were 
isolated from urogenital infections. These uropatho-
gens were found to be multidrug resistant, especially 
Klebsiella sp. GF01, which was completely resistant to 
all the antibiotics tested in this study. This high pheno-
typic resistance is making the present antibiotic therapy 
for bacterial infections ineffective thereby resulting in 
more search for naturally occurring remedies, e.g. LAB 
(Ayeni et al. 2011).
The species of beneficial bacteria identified from 
the vaginal samples in this study were L. fermentum, 
L. brevis, L. plantarum, B. safensis, and A. pasteurianus. 
Out of 27 isolates, 25 isolates were lactobacilli where 
L. plantarum and L. fermentum were the most predom-
inant species, with L. plantarum having the highest 
occurrence during the ovulation period. Dareng et al. 
(2016) also reported Lactobacillus iners and Lactobacil­
lus crispatus in the vagina of Nigerian women, while 
a study of vaginal Lactobacillus strain in the pregnant 
Korean women reported prevalence of L. crispatus and 
L. iners, followed by L. gasseri and L. jensenii (Kim et al. 
2017). There are versatility and species diversity in the 
prevalent lactobacilli present in the vagina. This can 
stem from different lifestyles, geographical and envi-
ronmental conditions. There is usually a predominance 
of Lactobacillus in healthy women, including L. iners and 
L. crispatus in women in the reproductive age (Xu et al. 
2013; Ghartey et al. 2014). However, there may be also 
a complete absence of lactobacilli in the other appar-
ently healthy women. This is in accordance with this 
study, in which twenty-seven LAB were isolated from 
the vagina of seven healthy Nigerian women out of the 
ten volunteers, while no the LAB was detected in three 
of the women. This result of the LAB absence in women 
could be due to immunosuppression. Other factors 
could include infections, stress, nutrition intake, etc.
Fig 2. Inhibition of in vitro growth of Staphylococcus sp. GF01 by 
L. brevis GF021, L. fermentum GF002, L. plantarum GF011, and 
L. fermentum GF019 at 8 and 24 h of coincubation.
Fig 1. Inhibition of in vitro growth of Staphylococcus sp. GF01 by 
L. brevis GF021, L. fermentum GF002, L. plantarum GF011, and 
L. fermentum GF019 after 24 h – coincubation.
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Many researchers have reported the prevalence 
of different LAB species isolated from the vagina of 
women from different geographical area (Gajer et al. 
2012; Chaban et al. 2014; Shiraishi et al. 2011), but few 
have been able to report the type of LAB present or 
absent during the different stages of a woman’s men-
strual cycle in different countries and specific ethnic 
aspects; this could influence the structure of the micro-
biota in specific niches. It was observed that during the 
menstruating period, the LAB count was low while at 
the safe/follicular period, the presence of the LAB was 
greater, but a large amount of LAB was found at the 
latter part of the cycle. Thereby, there was a significant 
shift in the LAB level from low to high over the course 
of the menstrual cycle. Menstruation may enhance 
a distortion of the bacterial microbiota around the 
vulva (Shiraishi et al. 2011) and influence Lactobacillus 
spp. which were the dominant organism in most girls 
before the onset of menses from the early to middle 
stages of puberty (Hickey et al. 2015).
The absence or low the LAB count during menses 
may suggest the growth of yeast which can outgrow the 
bacteria in immunocompromised patients causing yeast 
and other urogenital infections. However, during safe 
and ovulation periods when the LAB count is increas-
ing there is a decrease in the yeast count probably due 
to the antagonistic effect of these LAB on yeast or the 
hormonal changes taking place during these periods 
(Relloso et al. 2012). Women may be more susceptible 
to urogenital tract infections during the menstruation 
period compared to the ovulation period due to the 
high prevalence of the LAB during the ovulation period. 
The dynamic nature of the vaginal environment leads 
to changes in the microbiota of the vagina as a result 
of exposure to pathogens and physiologic fluctuations 
of the menstrual cycle (Farage et al. 2010). In the course 
of this study, L. plantarum dominated during the ovula-
tion period, L. brevis was found during menstruation 
and B. safensis during the safe period. The presence of 
these organisms at different periods can be attributed 
to change in vagina pH, hormonal change and even the 
blood flow during menses.
Lactobacilli isolated from the vagina have a promi-
nent role as a prophylactic aimed at improving the 
vaginal microbiota defense against bacterial infec-
tions. The cell-free supernatant and the viable LAB 
cells exhibited capabilities to inhibit the growth of the 
uropathogens, albeit to a different extent. The vaginal 
strains of L. acidophilus had been reported to inhibit 
the growth of Klebsiella sp. and some other uropatho-
genic strains (Ayeni and Adeniyi 2012; Adeoshun and 
Ayeni 2016). Most of the L. plantarum strains showed 
the most impressive effect. The antagonistic activity 
of L. brevis GF021 was also appreciable. It was sug-
gested that the organic acid produced by these LAB 
play a major role in the antagonistic activity because 
after neutralization, there was no obvious effect. This 
result agrees with Ayeni et al. (2011) who reported that 
the antimicrobial properties of LAB are related to their 
metabolic products such as organic acids and hydrogen 
peroxide. Non-lactic acid bacterial strains i.e. B. safensis 
and A. pasteurianus also could inhibit the uropathogens 
growth. To the best of our knowledge, this is the first 
study that will report the presence of these two species 
in the vagina of a woman. B. safensis has biotechno-
logical and industrial potentials (Larboda et al. 2014) 
while A. pasteurianus is important in vinegar produc-
tion (Viana et al. 2017). The mechanism by which this 
organism inhibits the three uropathogens used in this 
study is probably due to the production of acetic acid.
The resistance of S. aureus strain to the cell-free 
supernatant from most of the LAB strains in this study 
prompted another mechanism of antagonism through 
co-culture experiment. Bamidele et al. (2013) also 
reported that methicillin-resistant S. aureus (MRSA) 
strains were resistant to the cell-free supernatants of the 
LAB but higher activities were shown when the LAB 
was in contact with the pathogens. Different LAB strains 
have different rates of the killing of Staphylococcus sp. 
GF01. In the first experiment, the growth of Staphylo­
coccus sp. GF01 was not influenced by the presence of 
the lactobacilli while for the second experiment, the 8 
h already grown Staphylococcus sp. GF01 overpowered 
the LAB activity, except for L. brevis. Very good activity 
demonstrated the strain L. brevis GR01. There was an 
inhibition (5 log10 reduction) observed only when the 
pathogen was freshly introduced but no effect was noted 
towards the 8 h already grown pathogen. The study of 
Adetoye et al. (2018) reveals a similar process where it 
was reported that an effective inhibition was observed 
when the LAB was co-cultured with the pathogens. The 
presence of the LAB inhibited the growth of Staphylococ­
cus sp. GF01 freshly introduced, while for the already 
8 h grown Staphylococcus sp. GF01, the effect of LAB 
was not obvious, except for L. brevis. It was suggested 
that Staphylococcus sp. GF01 was able to overpower or 
suppress the activity of the LAB. The decrease in the 
number of Staphylococcus sp. GF01 reveals the antimi-
crobial activity of the LAB cells against Staphylococcus 
sp. GF01. These data support the result obtained previ-
ously using the cell-free supernatant and the viable LAB 
cells confirming the high resistance of Staphylococcus sp. 
GF01 to the LAB strains.
Conclusion
The high LAB counts were found during the ovu-
lation period while during menstruation, there was 
a decrease in the LAB counts. The highest occurrence 
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in the vagina of Nigerian women was shown for L. plan­
tarum that mostly was found during the ovulation 
period. The LAB isolated has the antimicrobial prop-
erties against multidrug-resistant urogenital pathogens 
what may be applicable in vivo. The fermented foods 
such as Ogi, yogurt, etc. can be consumed during men-
struation in order to replenish the beneficial bacteria. 
To the best of our knowledge, this is the first study in 
Nigeria to report a prevalence of the LAB with their 
protective role at different stages of a woman’s menstrual 
cycle and also the first study to show the presence of 
B. safensis and A. pasteurianus in the vagina of a woman.
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